Abbott Vascular Inc - Product Pipeline Analysis, 2017 Update
"Abbott
Vascular Inc - Product Pipeline Analysis, 2017 Update"
The Report covers current Industries Trends, Worldwide Analysis,
Global Forecast, Review, Share, Size, Growth, Effect.
Description-
Summary
Abbott Vascular Inc (Abbott Vascular), formerly Perclose, Inc., a subsidiary of Abbott Laboratories, is a medical device company that develops manufactures and markets cardiovascular devices. The company offers coronary intervention, peripheral intervention, and structural heart products. Its coronary intervention products include bleedback control valve, coronary dilatation catheters, coronary drug eluting stents, coronary guide wires, and others. Abbott Vasculars peripheral intervention products comprise peripheral guide wires, dilatation catheters, guiding catheters, and stent grafts. The company provides minimally invasive treatment for mitral regurgitation and other structural defects of the heart. It also offers education and training services for healthcare professionals. Abbott Vascular is headquartered in Santa Clara, California, the US.
Abbott Vascular Inc (Abbott Vascular), formerly Perclose, Inc., a subsidiary of Abbott Laboratories, is a medical device company that develops manufactures and markets cardiovascular devices. The company offers coronary intervention, peripheral intervention, and structural heart products. Its coronary intervention products include bleedback control valve, coronary dilatation catheters, coronary drug eluting stents, coronary guide wires, and others. Abbott Vasculars peripheral intervention products comprise peripheral guide wires, dilatation catheters, guiding catheters, and stent grafts. The company provides minimally invasive treatment for mitral regurgitation and other structural defects of the heart. It also offers education and training services for healthcare professionals. Abbott Vascular is headquartered in Santa Clara, California, the US.
Get
Sample
Report
With TOC @
http://www.researchmoz.us/enquiry.php?type=S&repid=1149989
This
report is a source for data, analysis, and actionable intelligence on
the companys portfolio of pipeline products. The report provides key
information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Abbott Vascular Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Abbott Vascular Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table
of Contents
Table
of Contents 2
List of Tables 4
List of Figures 5
Abbott Vascular Inc Company Overview 6
Abbott Vascular Inc Company Snapshot 6
Abbott Vascular Inc Pipeline Products and Ongoing Clinical Trials Overview 6
Abbott Vascular Inc Pipeline Analysis Overview 9
Abbott Vascular Inc - Key Facts 9
Abbott Vascular Inc - Major Products and Services 10
Abbott Vascular Inc Pipeline Products by Development Stage 11
Abbott Vascular Inc Ongoing Clinical Trials by Trial Status 13
Abbott Vascular Inc Pipeline Products Overview 17
Absorb GT1 Bioresorbable Vascular Scaffold 17
Absorb GT1 Bioresorbable Vascular Scaffold Product Overview 17
Absorb GT1 Bioresorbable Vascular Scaffold Clinical Trial 18
Chemical RDN System 31
Chemical RDN System Product Overview 31
Emboshield Pro Rapid Exchange Embolic Protection System (Generation 5) 32
Emboshield Pro Rapid Exchange Embolic Protection System (Generation 5) Product Overview 32
ESPRIT Bioresorbable Vascular Scaffold 33
ESPRIT Bioresorbable Vascular Scaffold Product Overview 33
Next Generation SUPERA Delivery System 34
Next Generation SUPERA Delivery System Product Overview 34
Second Generation Bioresorbable Vascular Scaffold 35
Second Generation Bioresorbable Vascular Scaffold Product Overview 35
Tendyne Bioprosthetic Mitral Valve Implantation System 36
Tendyne Bioprosthetic Mitral Valve Implantation System Product Overview 36
Tendyne Bioprosthetic Mitral Valve Implantation System Clinical Trial 37
Xience SBA Everolimus Eluting Coronary Stent System 38
Xience SBA Everolimus Eluting Coronary Stent System Product Overview 38
XIENCE Thinman DES 39
XIENCE Thinman DES Product Overview 39
ZoMaxx Drug Eluting Coronary Stent System 40
ZoMaxx Drug Eluting Coronary Stent System Product Overview 40
Abbott Vascular Inc - Key Competitors 41
Abbott Vascular Inc - Key Employees 42
Abbott Vascular Inc - Locations And Subsidiaries 43
Head Office 43
Recent Developments 44
Abbott Vascular Inc, Recent Developments 44
May 12, 2017: Abbott Initiates Voluntarily Recall of NC Tenku RX PTCA Balloon Catheter 44
May 12, 2017: Abbott Initiates Voluntarily Recall of NC Traveler Coronary Dilatation Catheter 44
May 12, 2017: Abbott Initiates Voluntarily Recall of Specific Lots of NC Trek RX Coronary Dilatation Catheter 44
May 02, 2017: TGA Hazard Alert On Absorb Bioresorbable Vascular Scaffold System 45
Mar 27, 2017: Abbott Vascular Provides Update On Absorb Bioresorbable Vascular Scaffold 45
Mar 18, 2017: Absorb GT1 Bioresorbable Vascular Scaffold by Abbott Vascular: Letter to Health Care Providers - FDA Investigating Increased Rate of Major Adverse Cardiac Events 45
List of Tables 4
List of Figures 5
Abbott Vascular Inc Company Overview 6
Abbott Vascular Inc Company Snapshot 6
Abbott Vascular Inc Pipeline Products and Ongoing Clinical Trials Overview 6
Abbott Vascular Inc Pipeline Analysis Overview 9
Abbott Vascular Inc - Key Facts 9
Abbott Vascular Inc - Major Products and Services 10
Abbott Vascular Inc Pipeline Products by Development Stage 11
Abbott Vascular Inc Ongoing Clinical Trials by Trial Status 13
Abbott Vascular Inc Pipeline Products Overview 17
Absorb GT1 Bioresorbable Vascular Scaffold 17
Absorb GT1 Bioresorbable Vascular Scaffold Product Overview 17
Absorb GT1 Bioresorbable Vascular Scaffold Clinical Trial 18
Chemical RDN System 31
Chemical RDN System Product Overview 31
Emboshield Pro Rapid Exchange Embolic Protection System (Generation 5) 32
Emboshield Pro Rapid Exchange Embolic Protection System (Generation 5) Product Overview 32
ESPRIT Bioresorbable Vascular Scaffold 33
ESPRIT Bioresorbable Vascular Scaffold Product Overview 33
Next Generation SUPERA Delivery System 34
Next Generation SUPERA Delivery System Product Overview 34
Second Generation Bioresorbable Vascular Scaffold 35
Second Generation Bioresorbable Vascular Scaffold Product Overview 35
Tendyne Bioprosthetic Mitral Valve Implantation System 36
Tendyne Bioprosthetic Mitral Valve Implantation System Product Overview 36
Tendyne Bioprosthetic Mitral Valve Implantation System Clinical Trial 37
Xience SBA Everolimus Eluting Coronary Stent System 38
Xience SBA Everolimus Eluting Coronary Stent System Product Overview 38
XIENCE Thinman DES 39
XIENCE Thinman DES Product Overview 39
ZoMaxx Drug Eluting Coronary Stent System 40
ZoMaxx Drug Eluting Coronary Stent System Product Overview 40
Abbott Vascular Inc - Key Competitors 41
Abbott Vascular Inc - Key Employees 42
Abbott Vascular Inc - Locations And Subsidiaries 43
Head Office 43
Recent Developments 44
Abbott Vascular Inc, Recent Developments 44
May 12, 2017: Abbott Initiates Voluntarily Recall of NC Tenku RX PTCA Balloon Catheter 44
May 12, 2017: Abbott Initiates Voluntarily Recall of NC Traveler Coronary Dilatation Catheter 44
May 12, 2017: Abbott Initiates Voluntarily Recall of Specific Lots of NC Trek RX Coronary Dilatation Catheter 44
May 02, 2017: TGA Hazard Alert On Absorb Bioresorbable Vascular Scaffold System 45
Mar 27, 2017: Abbott Vascular Provides Update On Absorb Bioresorbable Vascular Scaffold 45
Mar 18, 2017: Absorb GT1 Bioresorbable Vascular Scaffold by Abbott Vascular: Letter to Health Care Providers - FDA Investigating Increased Rate of Major Adverse Cardiac Events 45
Comments
Post a Comment